Cargando…
Isolated adrenocorticotropic hormone deficiency following immune checkpoint inhibitors treatment often occurs in polyglandular endocrinopathies
BACKGROUND: With the increasing application of immune checkpoint inhibitors (ICI) in cancer therapy, the occurrence of isolated adrenocorticotropic hormone deficiency (IAD), as an adverse effect, is also on the rise. Nevertheless, there are only a few studies regarding IAD induced by ICI. This study...
Autores principales: | Chen, Hong, Zhang, Lei, Zhao, Lin, Li, Xiaomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324167/ https://www.ncbi.nlm.nih.gov/pubmed/37415148 http://dx.doi.org/10.1186/s12902-023-01397-0 |
Ejemplares similares
-
Immune Checkpoint Inhibitor-related Endocrinopathies
por: Lu, Difei, et al.
Publicado: (2022) -
Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody
por: Urai, Shin, et al.
Publicado: (2023) -
Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment
por: Shalit, Almog, et al.
Publicado: (2023) -
Petrified Ear Auricles with Isolated Adrenocorticotropic Hormone Deficiency
por: Taguchi, Takafumi, et al.
Publicado: (2017) -
Editorial: Decoding checkpoint inhibitor-induced endocrinopathies
por: Burnett, Deborah L., et al.
Publicado: (2022)